Cabaletta Bio, Inc. Profile Avatar - Palmy Investing

Cabaletta Bio, Inc.

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor…

Biotechnology
US, Philadelphia [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Cabaletta Bio, Inc. (CABA) to it's peer group.

Peer Group
Loading...
End of CABA's Analysis
CIK: 1759138 CUSIP: 12674W109 ISIN: US12674W1099 LEI: - UEI: -
Secondary Listings
CABA has no secondary listings inside our databases.